Australia vs Hong Kong, China: Treatment success rate: XDR-TB cases
Australia
100
in 2022
Hong Kong, China
100
in 2022
Australia rank
1st
Hong Kong, China rank
1st
Treatment success rate: XDR-TB cases over time
- Australia
- Hong Kong, China
How they compare
Australia currently reports 100 against 100 in Hong Kong, China, a difference of 0.
Across all 7 years both countries report, Hong Kong, China has been ahead every year.
Australia ranks 1st and Hong Kong, China ranks 1st of 82 countries.
Hong Kong, China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Hong Kong, China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.75 | 91.75 | 25 | Hong Kong, China |
| 2020s | 77.67 | 89 | 11.33 | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Australia or Hong Kong, China?
- Australia, at 100 against 100 in Hong Kong, China as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Australia and Hong Kong, China?
- 0, with Australia ahead.
- How many years of comparable data are there for Australia and Hong Kong, China?
- 7 years are reported by both, from 2010 to 2022.
- How do Australia and Hong Kong, China rank globally for treatment success rate: xdr-tb cases?
- Australia ranks 1st and Hong Kong, China ranks 1st of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.